Skip to main content
. 2014 Jun 23;9(6):e100295. doi: 10.1371/journal.pone.0100295

Figure 3. Identification of overexpressed genes with increased copy numbers in breast cancer by different autoregressive HMMs.

Figure 3

Systematic comparison of the identification of overexpressed genes with at least three-fold increased copy numbers by autoregressive HMMs based on breast cancer gene expression profiles from [3]. Each AR(Inline graphic)-HMM(Inline graphic) with an emission process of order Inline graphic (AR(Inline graphic)) in combination with a state-transition process of order Inline graphic (HMM-Order) is considered. The left column shows the performances reached by autoregressive HMMs trained and applied to fifty percent of the breast cancer gene expression data. The right column shows the performances of these models reached on the remaining unseen fifty percent of the data set. For each model, the identification of candidate genes of overexpression with at least three-fold increased copy numbers is quantified by the true positive rate (TPR) reached at a fixed false positive rate of 5%. Six different scenarios are shown. a) and b) represent performances of the different models with respect to our standard initial model parameter settings. c) and d) represent average performances and corresponding standard deviations reached with respect to systematically changed initial model parameters. e) and f) represent average performances and corresponding standard deviations reached with respect to systematically modified prior hyperparameter settings. The predictions of autoregressive HMMs are generally very robust. Models utilizing a combination of higher-order state-transitions and autoregressive emissions (e.g. AR(Inline graphic)-HMM(Inline graphic) and AR(Inline graphic)-HMM(Inline graphic)) are clearly outperforming the mixture model (AR(Inline graphic)-HMM(Inline graphic)), the standard first-order HMM (AR(Inline graphic)-HMM(Inline graphic)), and standard higher-order HMMs (AR(Inline graphic)-HMM(Inline graphic)).